Gyre Therapeutics Inc.

8.88
0.94 (11.84%)
At close: Apr 17, 2025, 3:59 PM
8.55
-3.72%
Pre-market: Apr 21, 2025, 05:42 AM EDT

Gyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
17.9M -85.48M -8.24M -87.93M -56.24M -55.18M -30.05M -21.56M -16.95M
1.55M 1.11M 230K 290K 138K 146K 149K 173K 389K
831K 7.28M 13.37M -283.18K 3.63M 3.2M 2.61M 863K 635K
n/a 4.22M 541K -5.39M -12.87M 20.67M -1.87M 650K 477K
-23.92M 96.68M -21.48M 3.89M 1.05M 11.42M 116K 18K -3.39M
n/a -1.16M -838K -3.89M -1.05M -11.42M n/a n/a n/a
n/a 7.46M -4.95M 483K -2.57M 8.21M -1.37M 567K 836K
-3.64M 25.89M -33.1M -83.75M -55.05M -43.61M -28.55M -19.94M -18.47M
-2.31M -8.59M -5M -839K -267K -64K -376K -23K -468K
n/a 4.02M 55.5M n/a -9.93M -27.46M n/a n/a 890K
-1.69M -15.73M -50.51M n/a -97.64M -129.98M -198.91M -25.47M -13.4M
n/a n/a 57.5M 49.03M 107.56M 157.43M 127.97M 14.3M 10M
-15.88M 471K -2.06M 49.03M 9.93M 27.46M -70.94M -57K 2.56M
-19.88M -19.76M 55.43M 48.19M 9.66M 27.39M -71.32M -11.25M -1.31M
n/a n/a n/a n/a n/a n/a -5.08M -14.32M -10K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a -45.03M n/a n/a n/a n/a -3.95M n/a
1.33M n/a 20K n/a n/a n/a n/a 18.27M n/a
2.1M 2.5M -45.01M 49.55M 60.38M 327K 111.33M 35.4M 948K
-21.7M 8.33M -22.68M 13.99M 14.99M -15.89M 11.46M 4.21M -18.83M
-5.96M 17.31M -38.09M -84.59M -55.31M -43.68M -28.93M -19.96M -18.94M